EMJ GOLD
@emjgold.bsky.social
The latest pharma news, views and analysis.
Sign up to our mailing list to receive insights direct to your inbox: https://emjreviews.com/mailing-list/
Sign up to our mailing list to receive insights direct to your inbox: https://emjreviews.com/mailing-list/
Pinned
EMJ GOLD
@emjgold.bsky.social
· 15d
What is a next-gen patient case study?
In our latest feature, we look at interactive case studies to find out what they can do, how they work and why they meet the needs of time starved healthcare professionals.
Read now: www.emjreviews.com/emj-gold/art...
In our latest feature, we look at interactive case studies to find out what they can do, how they work and why they meet the needs of time starved healthcare professionals.
Read now: www.emjreviews.com/emj-gold/art...
Did you know? Scotland generates 20% of the UK's clinical trial revenue.
Now, the country has announced a major new plan to grow its life sciences sector to a £25bn turnover by 2035, aiming to significantly boost healthcare innovation.
Read full story: www.emjreviews.com/emj-gold/new...
Now, the country has announced a major new plan to grow its life sciences sector to a £25bn turnover by 2035, aiming to significantly boost healthcare innovation.
Read full story: www.emjreviews.com/emj-gold/new...
November 21, 2025 at 2:51 PM
Did you know? Scotland generates 20% of the UK's clinical trial revenue.
Now, the country has announced a major new plan to grow its life sciences sector to a £25bn turnover by 2035, aiming to significantly boost healthcare innovation.
Read full story: www.emjreviews.com/emj-gold/new...
Now, the country has announced a major new plan to grow its life sciences sector to a £25bn turnover by 2035, aiming to significantly boost healthcare innovation.
Read full story: www.emjreviews.com/emj-gold/new...
“There comes a day when cancer knocks on your own door.”
In our latest Catalyst interview, hear from AstraZeneca's Dr Vikram Chand, as he reveals how a family experience with cancer altered his views on clinical trial design and much more.
Watch now: www.emjreviews.com/emj-gold/art...
In our latest Catalyst interview, hear from AstraZeneca's Dr Vikram Chand, as he reveals how a family experience with cancer altered his views on clinical trial design and much more.
Watch now: www.emjreviews.com/emj-gold/art...
November 19, 2025 at 4:03 PM
“There comes a day when cancer knocks on your own door.”
In our latest Catalyst interview, hear from AstraZeneca's Dr Vikram Chand, as he reveals how a family experience with cancer altered his views on clinical trial design and much more.
Watch now: www.emjreviews.com/emj-gold/art...
In our latest Catalyst interview, hear from AstraZeneca's Dr Vikram Chand, as he reveals how a family experience with cancer altered his views on clinical trial design and much more.
Watch now: www.emjreviews.com/emj-gold/art...
What is it like to live with chronic lymphocytic leukaemia?
AbbVie's new documentary offers a window into the lives of three patients living with the disease.
Read more: www.emjreviews.com/emj-gold/new...
AbbVie's new documentary offers a window into the lives of three patients living with the disease.
Read more: www.emjreviews.com/emj-gold/new...
November 17, 2025 at 5:07 PM
What is it like to live with chronic lymphocytic leukaemia?
AbbVie's new documentary offers a window into the lives of three patients living with the disease.
Read more: www.emjreviews.com/emj-gold/new...
AbbVie's new documentary offers a window into the lives of three patients living with the disease.
Read more: www.emjreviews.com/emj-gold/new...
Orion Corporation has won Finland's Presidential prize for its global growth.
It won the award for its responsible business practices and role in bringing Finnish medical innovation to the world stage.
Learn more: www.emjreviews.com/emj-gold/new...
It won the award for its responsible business practices and role in bringing Finnish medical innovation to the world stage.
Learn more: www.emjreviews.com/emj-gold/new...
November 14, 2025 at 5:16 PM
Orion Corporation has won Finland's Presidential prize for its global growth.
It won the award for its responsible business practices and role in bringing Finnish medical innovation to the world stage.
Learn more: www.emjreviews.com/emj-gold/new...
It won the award for its responsible business practices and role in bringing Finnish medical innovation to the world stage.
Learn more: www.emjreviews.com/emj-gold/new...
In the latest podcast episode, Giuseppe Savoja, Senior Business Director, Cardiac Surgery in Western Europe at Medtronic, breaks down:
• Today’s ICU challenges
• How ECMO has evolved
• Why industry–clinician collaboration matters
Watch now: www.emjreviews.com/emj-gold/pod...
• Today’s ICU challenges
• How ECMO has evolved
• Why industry–clinician collaboration matters
Watch now: www.emjreviews.com/emj-gold/pod...
November 14, 2025 at 11:59 AM
In the latest podcast episode, Giuseppe Savoja, Senior Business Director, Cardiac Surgery in Western Europe at Medtronic, breaks down:
• Today’s ICU challenges
• How ECMO has evolved
• Why industry–clinician collaboration matters
Watch now: www.emjreviews.com/emj-gold/pod...
• Today’s ICU challenges
• How ECMO has evolved
• Why industry–clinician collaboration matters
Watch now: www.emjreviews.com/emj-gold/pod...
Check out our latest '5 minutes with...' interview featuring Benedikt von Thüngen, Founder and CEO, Sanome, as he explains 'the why' behind his business, its biggest challenge to date and what pharma needs to know about AI.
Read now: www.emjreviews.com/emj-gold/art...
Read now: www.emjreviews.com/emj-gold/art...
November 12, 2025 at 2:16 PM
Check out our latest '5 minutes with...' interview featuring Benedikt von Thüngen, Founder and CEO, Sanome, as he explains 'the why' behind his business, its biggest challenge to date and what pharma needs to know about AI.
Read now: www.emjreviews.com/emj-gold/art...
Read now: www.emjreviews.com/emj-gold/art...
Did you know? Only 51% of low- and middle-income countries can access a life-extending advanced breast cancer treatment.
Our review of VML Health's report explores this issue and insights into research, outcomes and care over the past decade.
Read now: www.emjreviews.com/emj-gold/new...
Our review of VML Health's report explores this issue and insights into research, outcomes and care over the past decade.
Read now: www.emjreviews.com/emj-gold/new...
November 11, 2025 at 2:12 PM
Did you know? Only 51% of low- and middle-income countries can access a life-extending advanced breast cancer treatment.
Our review of VML Health's report explores this issue and insights into research, outcomes and care over the past decade.
Read now: www.emjreviews.com/emj-gold/new...
Our review of VML Health's report explores this issue and insights into research, outcomes and care over the past decade.
Read now: www.emjreviews.com/emj-gold/new...
What is a next-gen patient case study?
In our latest feature, we look at interactive case studies to find out what they can do, how they work and why they meet the needs of time starved healthcare professionals.
Read now: www.emjreviews.com/emj-gold/art...
In our latest feature, we look at interactive case studies to find out what they can do, how they work and why they meet the needs of time starved healthcare professionals.
Read now: www.emjreviews.com/emj-gold/art...
November 6, 2025 at 3:47 PM
What is a next-gen patient case study?
In our latest feature, we look at interactive case studies to find out what they can do, how they work and why they meet the needs of time starved healthcare professionals.
Read now: www.emjreviews.com/emj-gold/art...
In our latest feature, we look at interactive case studies to find out what they can do, how they work and why they meet the needs of time starved healthcare professionals.
Read now: www.emjreviews.com/emj-gold/art...
To stay or to go? #VPAG edition.
The ABPI has announced a two week extension for organisations to submit notice on whether they want to be part of scheme in 2026.
Read our write up exploring the issue: www.emjreviews.com/emj-gold/new...
The ABPI has announced a two week extension for organisations to submit notice on whether they want to be part of scheme in 2026.
Read our write up exploring the issue: www.emjreviews.com/emj-gold/new...
New VPAG deadline extension announced by ABPI
The UK government has extended the deadline for organisations to submit notice to leave the scheme by two additional weeks.
www.emjreviews.com
October 28, 2025 at 3:41 PM
To stay or to go? #VPAG edition.
The ABPI has announced a two week extension for organisations to submit notice on whether they want to be part of scheme in 2026.
Read our write up exploring the issue: www.emjreviews.com/emj-gold/new...
The ABPI has announced a two week extension for organisations to submit notice on whether they want to be part of scheme in 2026.
Read our write up exploring the issue: www.emjreviews.com/emj-gold/new...
📣 Novartis to buy Avidity Biosciences for $12bn
The acquisition is part of a growing trend for RNA-based precision medicine, reflected in a surge of deals across the pharma industry in 2025.
Discover the trend: www.emjreviews.com/emj-gold/new...
The acquisition is part of a growing trend for RNA-based precision medicine, reflected in a surge of deals across the pharma industry in 2025.
Discover the trend: www.emjreviews.com/emj-gold/new...
Novartis bets $12bn on RNA with Avidity buy
Novartis to acquire Avidity Biosciences for $12bn, boosting its RNA neuromuscular pipeline as pharma M&A heats up in the RNA space.
www.emjreviews.com
October 27, 2025 at 4:49 PM
📣 Novartis to buy Avidity Biosciences for $12bn
The acquisition is part of a growing trend for RNA-based precision medicine, reflected in a surge of deals across the pharma industry in 2025.
Discover the trend: www.emjreviews.com/emj-gold/new...
The acquisition is part of a growing trend for RNA-based precision medicine, reflected in a surge of deals across the pharma industry in 2025.
Discover the trend: www.emjreviews.com/emj-gold/new...
Google’s new quantum chip just outpaced the world’s fastest supercomputers - and it could change how we design drugs and model molecules.
Has the future of drug discovery just shifted?
Read our full release: www.emjreviews.com/emj-gold/new...
Has the future of drug discovery just shifted?
Read our full release: www.emjreviews.com/emj-gold/new...
Google quantum chip could speed up drug discovery
Google’s Quantum Echoes breakthrough could revolutionise drug discovery, offering faster, more precise ways to design new medicines.
www.emjreviews.com
October 24, 2025 at 10:10 AM
Google’s new quantum chip just outpaced the world’s fastest supercomputers - and it could change how we design drugs and model molecules.
Has the future of drug discovery just shifted?
Read our full release: www.emjreviews.com/emj-gold/new...
Has the future of drug discovery just shifted?
Read our full release: www.emjreviews.com/emj-gold/new...
"Cut VPAG in half tomorrow, and lower corporation tax to compete with Europe the day after"
Discover what bold steps are needed to make the UK a destination of choice for pharma once more, with insight from two experts in the industry.
Read the roundtable: www.emjreviews.com/emj-gold/art...
Discover what bold steps are needed to make the UK a destination of choice for pharma once more, with insight from two experts in the industry.
Read the roundtable: www.emjreviews.com/emj-gold/art...
October 23, 2025 at 10:25 AM
"Cut VPAG in half tomorrow, and lower corporation tax to compete with Europe the day after"
Discover what bold steps are needed to make the UK a destination of choice for pharma once more, with insight from two experts in the industry.
Read the roundtable: www.emjreviews.com/emj-gold/art...
Discover what bold steps are needed to make the UK a destination of choice for pharma once more, with insight from two experts in the industry.
Read the roundtable: www.emjreviews.com/emj-gold/art...
💉 Are cell-based vaccines the future?
CSL Seqirus thinks so. New real-world data commissioned by the company show that cell-based flu vaccines provided 20% greater protection than egg-based options during the 2023/24 flu season.
Read now: www.emjreviews.com/emj-gold/new...
CSL Seqirus thinks so. New real-world data commissioned by the company show that cell-based flu vaccines provided 20% greater protection than egg-based options during the 2023/24 flu season.
Read now: www.emjreviews.com/emj-gold/new...
Cell-based flu vaccines offer 20% more protection
CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.
www.emjreviews.com
October 22, 2025 at 1:48 PM
💉 Are cell-based vaccines the future?
CSL Seqirus thinks so. New real-world data commissioned by the company show that cell-based flu vaccines provided 20% greater protection than egg-based options during the 2023/24 flu season.
Read now: www.emjreviews.com/emj-gold/new...
CSL Seqirus thinks so. New real-world data commissioned by the company show that cell-based flu vaccines provided 20% greater protection than egg-based options during the 2023/24 flu season.
Read now: www.emjreviews.com/emj-gold/new...
🧠 New partnership in brain health
Lundbeck is stepping into RNA-targeted drug discovery via a collaboration with Contera Pharma, with hopes to identify new oligonucleotide-based therapies.
Read now: emjreviews.com/emj-gold/news/lundbeck-and-contera-partner-on-rna-targeted-drug-discovery/
Lundbeck is stepping into RNA-targeted drug discovery via a collaboration with Contera Pharma, with hopes to identify new oligonucleotide-based therapies.
Read now: emjreviews.com/emj-gold/news/lundbeck-and-contera-partner-on-rna-targeted-drug-discovery/
Lundbeck and Contera partner on RNA-targeted drug discovery
Lundbeck is partnering with Contera Pharma to accelerate RNA-targeted drug discovery for serious neurological conditions.
emjreviews.com
October 21, 2025 at 4:12 PM
🧠 New partnership in brain health
Lundbeck is stepping into RNA-targeted drug discovery via a collaboration with Contera Pharma, with hopes to identify new oligonucleotide-based therapies.
Read now: emjreviews.com/emj-gold/news/lundbeck-and-contera-partner-on-rna-targeted-drug-discovery/
Lundbeck is stepping into RNA-targeted drug discovery via a collaboration with Contera Pharma, with hopes to identify new oligonucleotide-based therapies.
Read now: emjreviews.com/emj-gold/news/lundbeck-and-contera-partner-on-rna-targeted-drug-discovery/
AstraZeneca’s landmark deal with the White House promises up to 80% off drug prices, but what has the US government offered in return?
Find out here: www.emjreviews.com/emj-gold/new...
Find out here: www.emjreviews.com/emj-gold/new...
AstraZeneca to offer up to 80% off US drug prices
AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.
www.emjreviews.com
October 13, 2025 at 3:17 PM
AstraZeneca’s landmark deal with the White House promises up to 80% off drug prices, but what has the US government offered in return?
Find out here: www.emjreviews.com/emj-gold/new...
Find out here: www.emjreviews.com/emj-gold/new...
The NIHR has announced over £1.5m in funding for 17 innovative health tech projects across the UK.
Discover the recipients: www.emjreviews.com/emj-gold/new...
Discover the recipients: www.emjreviews.com/emj-gold/new...
NIHR funds £1.5m in innovative digital health projects
The UK's NIHR has funded £1.5M for 17 digital health projects to reduce paediatric mental health waiting times.
www.emjreviews.com
October 13, 2025 at 8:59 AM
The NIHR has announced over £1.5m in funding for 17 innovative health tech projects across the UK.
Discover the recipients: www.emjreviews.com/emj-gold/new...
Discover the recipients: www.emjreviews.com/emj-gold/new...
"It’s not just about removing inflammation, but for people to accept, like and feel comfortable in their skin again"
This #WorldMentalHealthDay, Dr Volker Koscielny, Almirall, explores the need to better address the mental health burden of skin conditions hubs.ly/Q03N3VZB0
This #WorldMentalHealthDay, Dr Volker Koscielny, Almirall, explores the need to better address the mental health burden of skin conditions hubs.ly/Q03N3VZB0
October 10, 2025 at 9:47 AM
"It’s not just about removing inflammation, but for people to accept, like and feel comfortable in their skin again"
This #WorldMentalHealthDay, Dr Volker Koscielny, Almirall, explores the need to better address the mental health burden of skin conditions hubs.ly/Q03N3VZB0
This #WorldMentalHealthDay, Dr Volker Koscielny, Almirall, explores the need to better address the mental health burden of skin conditions hubs.ly/Q03N3VZB0
A new biotech company believes the brain could hold the key to treating immune diseases.
Headed up by CEO Dr Kim Seth, #NiloTherapeutics have earned $101m in funding to explore their hypothesis.
Discover more: www.emjreviews.com/emj-gold/new...
Headed up by CEO Dr Kim Seth, #NiloTherapeutics have earned $101m in funding to explore their hypothesis.
Discover more: www.emjreviews.com/emj-gold/new...
Could the brain be a target for autoimmune disease?
A new biotech company Nilo Therapeutics believes the brain could hold the key to treating autoimmune diseases, with further studies to follow.
www.emjreviews.com
October 8, 2025 at 3:33 PM
A new biotech company believes the brain could hold the key to treating immune diseases.
Headed up by CEO Dr Kim Seth, #NiloTherapeutics have earned $101m in funding to explore their hypothesis.
Discover more: www.emjreviews.com/emj-gold/new...
Headed up by CEO Dr Kim Seth, #NiloTherapeutics have earned $101m in funding to explore their hypothesis.
Discover more: www.emjreviews.com/emj-gold/new...
Is £30,000 still the right price for a year of good health?
NICE's cost-effectiveness threshold hasn’t changed since 1999, and the @abpi.bsky.social says it’s time for a rethink.
Read the story: www.emjreviews.com/emj-gold/new...
NICE's cost-effectiveness threshold hasn’t changed since 1999, and the @abpi.bsky.social says it’s time for a rethink.
Read the story: www.emjreviews.com/emj-gold/new...
ABPI calls for NICE cost-effectiveness threshold review
ABPI is urging NICE to raise its cost-effectiveness threshold for new medicines, which has not been raised in over 20 years.
www.emjreviews.com
October 8, 2025 at 8:25 AM
Is £30,000 still the right price for a year of good health?
NICE's cost-effectiveness threshold hasn’t changed since 1999, and the @abpi.bsky.social says it’s time for a rethink.
Read the story: www.emjreviews.com/emj-gold/new...
NICE's cost-effectiveness threshold hasn’t changed since 1999, and the @abpi.bsky.social says it’s time for a rethink.
Read the story: www.emjreviews.com/emj-gold/new...
🧠 What if mind-controlled devices didn’t require invasive surgery?
A new study by Precision Neuroscience shows a surface-based brain-computer interface can capture high-resolution signals without opening the skull.
Read more: www.emjreviews.com/emj-gold/new...
A new study by Precision Neuroscience shows a surface-based brain-computer interface can capture high-resolution signals without opening the skull.
Read more: www.emjreviews.com/emj-gold/new...
Potential breakthrough in brain-computer interface research
New research from Precision Neuroscience shows its brain-computer interface can record high-resolution signals without invasive surgery.
www.emjreviews.com
October 3, 2025 at 4:03 PM
🧠 What if mind-controlled devices didn’t require invasive surgery?
A new study by Precision Neuroscience shows a surface-based brain-computer interface can capture high-resolution signals without opening the skull.
Read more: www.emjreviews.com/emj-gold/new...
A new study by Precision Neuroscience shows a surface-based brain-computer interface can capture high-resolution signals without opening the skull.
Read more: www.emjreviews.com/emj-gold/new...
UK healthcare stocks are powering the FTSE 100 to record highs - with AstraZeneca leading the charge and policy shifts in the US opening new doors for pharma. Could this be the turning point for the sector?
Read the full story here: www.emjreviews.com/emj-gold/new...
Read the full story here: www.emjreviews.com/emj-gold/new...
FTSE 100 hits new high as UK pharma stocks surge
UK pharma and healthcare stocks drive FTSE 100 to a record high, led by AstraZeneca, as trade policy shifts boost investor confidence.
www.emjreviews.com
October 2, 2025 at 3:53 PM
UK healthcare stocks are powering the FTSE 100 to record highs - with AstraZeneca leading the charge and policy shifts in the US opening new doors for pharma. Could this be the turning point for the sector?
Read the full story here: www.emjreviews.com/emj-gold/new...
Read the full story here: www.emjreviews.com/emj-gold/new...
Pharma headlines only tell part of the story.
Our brand-new monthly roundup goes further, sharing the context and analysis behind the biggest news. In this edition, learn about AI’s hidden risks and the off-label trends behind the GLP-1 boom.
Read now: www.emjreviews.com/emj-gold/new...
Our brand-new monthly roundup goes further, sharing the context and analysis behind the biggest news. In this edition, learn about AI’s hidden risks and the off-label trends behind the GLP-1 boom.
Read now: www.emjreviews.com/emj-gold/new...
October 2, 2025 at 8:25 AM
Pharma headlines only tell part of the story.
Our brand-new monthly roundup goes further, sharing the context and analysis behind the biggest news. In this edition, learn about AI’s hidden risks and the off-label trends behind the GLP-1 boom.
Read now: www.emjreviews.com/emj-gold/new...
Our brand-new monthly roundup goes further, sharing the context and analysis behind the biggest news. In this edition, learn about AI’s hidden risks and the off-label trends behind the GLP-1 boom.
Read now: www.emjreviews.com/emj-gold/new...
🚨 England’s first fully digital hospital is coming
Hear from NHS leaders and patient groups on what NHS Online could mean for the future of healthcare in England.
Read more: www.emjreviews.com/emj-gold/new...
Hear from NHS leaders and patient groups on what NHS Online could mean for the future of healthcare in England.
Read more: www.emjreviews.com/emj-gold/new...
NHS Online digital hospital to launch by 2027
England’s NHS is launching NHS Online, a fully digital hospital, to speed up specialist appointments, cut wait times and improve care access.
www.emjreviews.com
September 30, 2025 at 3:58 PM
🚨 England’s first fully digital hospital is coming
Hear from NHS leaders and patient groups on what NHS Online could mean for the future of healthcare in England.
Read more: www.emjreviews.com/emj-gold/new...
Hear from NHS leaders and patient groups on what NHS Online could mean for the future of healthcare in England.
Read more: www.emjreviews.com/emj-gold/new...
What could the tariffs mean for your company?
Announcing the plan on his Truth Social platform, President Trump said drugmakers could avoid the 100% duties if they have broken ground on a domestic plant on US soil.
Learn more: www.emjreviews.com/emj-gold/new...
#pharmatariffs
Announcing the plan on his Truth Social platform, President Trump said drugmakers could avoid the 100% duties if they have broken ground on a domestic plant on US soil.
Learn more: www.emjreviews.com/emj-gold/new...
#pharmatariffs
US pharma tariffs: Trump threatens 100% on imports
Donald Trump has threatened sweeping new tariffs on the pharma sector unless manufacturers commit to producing in the US.
www.emjreviews.com
September 26, 2025 at 10:12 AM
What could the tariffs mean for your company?
Announcing the plan on his Truth Social platform, President Trump said drugmakers could avoid the 100% duties if they have broken ground on a domestic plant on US soil.
Learn more: www.emjreviews.com/emj-gold/new...
#pharmatariffs
Announcing the plan on his Truth Social platform, President Trump said drugmakers could avoid the 100% duties if they have broken ground on a domestic plant on US soil.
Learn more: www.emjreviews.com/emj-gold/new...
#pharmatariffs
Social media: What does pharma need to know in 2025?
Discover key trends, challenges and opportunities, with some surprises in store, in our latest article.
Check it out now: www.emjreviews.com/emj-gold/art...
Discover key trends, challenges and opportunities, with some surprises in store, in our latest article.
Check it out now: www.emjreviews.com/emj-gold/art...
September 25, 2025 at 10:49 AM
Social media: What does pharma need to know in 2025?
Discover key trends, challenges and opportunities, with some surprises in store, in our latest article.
Check it out now: www.emjreviews.com/emj-gold/art...
Discover key trends, challenges and opportunities, with some surprises in store, in our latest article.
Check it out now: www.emjreviews.com/emj-gold/art...